A specially crafted compound that targets the protein MYCN in cancer cells can disrupt the protein's ability to stimulate tumor growth.
Nivolumab and dabrafenib plus trametinib up survival in melanoma without, with BRAF, respectively.
More than 70% of women who have had breast cancer experience menopausal problems, hot flushes in particular, and some cancer survivors consider giving up their post cancer medication to mitigate these conditions.
A new standard of care for children facing acute myeloid leukemia (AML) may be clear, following a multiyear study.
For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of over a thousand individuals.
Proportion undergoing testing varies by demographic and health-related factors, and by state, a study found.
Partial breast irradiation (APBI) with proton therapy, as opposed to whole breast irradiation (WBI), may prove more affordable and have a more beneficial length of treatment for patients with early stage breast cancer.
Patients with non-small lung cancer (NSCLC) that received postoperative radiation therapy (PORT) lived an average of 4 months longer, when compared with patients who had the same disease progression and treatment criteria.
Less than 20 percent of top-ranked health sites advise against screening for prostate cancer, a recommendation made by the USPSTF.
Circulating tumor cells can be detected well before the cancer becomes detectable on computed tomography (CT), according to new research, opening the possibility of early eradication of the primary cancer site.
A new, collaborative model in cancer care aims to reduce the rates at which patients go to intensive care or are readmitted to the hospital after discharge.
By utilizing both facial scanning software and 3-D printing, researchers have developed an inexpensive way to make facial prostheses for patients with eye cancer.
A federal prescription-subsidy program for low-income Medicare recipients has increased adherence to hormone therapy to prevent breast cancer recurrence after surgery, according to recent data.
Researchers have devised a new test to help doctors diagnose ovarian tumors and choose the most appropriate treatment.
A majority of of palliative care clinicians report burnout, according to a study, with the greatest risk of burnout for younger clinicians and those working more than 50 hours per week
- Risk prediction improved by new classification in chronic lymphocytic leukemia
- Treatment options for HER2-positive breast cancer
- Antimicrobial agent triclosan, used in soaps and detergents, may cause cancer
- The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer
- Disparities in non-small cell lung cancer (NSCLC) treatment based on race, treatment center
- A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
- Early palliative care can cut hospital readmissions for cancer patients
- ONA Interview: Breaking the barriers to effective palliative care
- Fluorescent tattoos may improve self-esteem in patients receiving radiotherapy for breast cancer
- Cancer prehabilitation: One step toward improved outcomes
- New approach to stop most-wanted cancer protein
- Survivors of pediatric retinoblastoma have few cognitive and social problems during adulthood
- Calorie-focused approach may mislead attempts to manage dietary choices
- Women with mental illness less likely to receive cancer screenings
- Combination treatments show promise for metastatic melanoma
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|